Clinical Trial Update: Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for hydroxychloroquine post-exposure prophylaxis in COVID-19 prevention (Phase 2/Phase 3) with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov Infection

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Regional Center for Disease Control and Prevention, Jordan | Conditions: SARS-CoV Infection | Phase 2, Phase 3 | Status: UNKNOWN